InfuSystem Holdings Inc. announced the appointment of Richard DiIorio as President and Chief Executive Officer, effective November 15, 2017. Mr. DiIorio has been elected to serve on the company's Board of Directors. With Mr. DiIorio's appointment, the Office of the President will cease to operate.

Mr. DiIorio brings a strong track record of accomplishment with more than seventeen years of medical sales experience, extensive expertise in product launch, and industry knowledge focused on driving growth in the oncology market. Mr. DiIorio has served as a member of the Company's Office of the President since May 2017 and as General Manager of Oncology since December 2016.